174 related articles for article (PubMed ID: 29355901)
21. Neck dissection for unknown cancer of the head and neck in the era of chemoradiation.
Amsbaugh MJ; Yusuf M; Gaskins J; Silverman C; Potts K; Bumpous J; Redman R; Perez C; Dunlap N
Am J Otolaryngol; 2017; 38(5):588-592. PubMed ID: 28633765
[TBL] [Abstract][Full Text] [Related]
22. The prognostic impact of depression or depressive symptoms on patients with head and neck cancer: A systematic review and meta-analysis.
Van der Elst S; Bardash Y; Wotman M; Kraus D; Tham T
Head Neck; 2021 Nov; 43(11):3608-3617. PubMed ID: 34525238
[TBL] [Abstract][Full Text] [Related]
23. Depressive Symptoms in Patients Scheduled for Hyperthermic Intraperitoneal Chemotherapy With Cytoreductive Surgery: Prospective Associations With Morbidity and Mortality.
Low CA; Bovbjerg DH; Ahrendt S; Alhelo S; Choudry H; Holtzman M; Jones HL; Pingpank JF; Ramalingam L; Zeh HJ; Zureikat AH; Bartlett DL
J Clin Oncol; 2016 Apr; 34(11):1217-22. PubMed ID: 26903574
[TBL] [Abstract][Full Text] [Related]
24. Impact of concomitant chemoradiation on survival for patients with T1-2N1 head and neck cancer.
Zumsteg ZS; Kim S; David JM; Yoshida EJ; Tighiouart M; Shiao SL; Scher K; Mita A; Sherman EJ; Lee NY; Ho AS
Cancer; 2017 May; 123(9):1555-1565. PubMed ID: 28001302
[TBL] [Abstract][Full Text] [Related]
25. Health-related quality of life in head and neck cancer survivors: impact of pretreatment depressive symptoms.
Howren MB; Christensen AJ; Karnell LH; Funk GF
Health Psychol; 2010 Jan; 29(1):65-71. PubMed ID: 20063937
[TBL] [Abstract][Full Text] [Related]
26. Assessment of tumor response to chemoradiotherapy and predicting prognosis in patients with head and neck squamous cell carcinoma by PERCIST.
Katsuura T; Kitajima K; Fujiwara M; Terada T; Uwa N; Noguchi K; Doi H; Tamaki Y; Yoshida R; Tsuchitani T; Fujita M; Yamakado K
Ann Nucl Med; 2018 Aug; 32(7):453-462. PubMed ID: 29858797
[TBL] [Abstract][Full Text] [Related]
27. Treatment trends and survival effects of chemotherapy for hypopharyngeal cancer: Analysis of the National Cancer Data Base.
Kuo P; Sosa JA; Burtness BA; Husain ZA; Mehra S; Roman SA; Yarbrough WG; Judson BL
Cancer; 2016 Jun; 122(12):1853-60. PubMed ID: 27019213
[TBL] [Abstract][Full Text] [Related]
28. Is sex an independent prognostic factor in cutaneous head and neck melanoma?
Arce PM; Camilon PR; Stokes WA; Nguyen SA; Lentsch EJ
Laryngoscope; 2014 Jun; 124(6):1363-7. PubMed ID: 24122966
[TBL] [Abstract][Full Text] [Related]
29. Risk of depressive disorder among patients with head and neck cancer: A nationwide population-based study.
Fan CY; Chao HL; Lin CS; Huang WY; Chen CM; Lin KT; Lin CL; Kao CH
Head Neck; 2018 Feb; 40(2):312-323. PubMed ID: 28963819
[TBL] [Abstract][Full Text] [Related]
30. Prediction of depressive symptomatology after treatment of head and neck cancer: the influence of pre-treatment physical and depressive symptoms, coping, and social support.
de Leeuw JR; de Graeff A; Ros WJ; Blijham GH; Hordijk GJ; Winnubst JA
Head Neck; 2000 Dec; 22(8):799-807. PubMed ID: 11084641
[TBL] [Abstract][Full Text] [Related]
31. Increased acute mortality with chemoradiotherapy for locally advanced head and neck cancer in patients ≥70years.
Strom TJ; Naghavi AO; Trotti AM; Russell J; Kish JA; McCaffrey J; Otto KJ; Harrison LB; Caudell JJ
J Geriatr Oncol; 2017 Jan; 8(1):50-55. PubMed ID: 27720129
[TBL] [Abstract][Full Text] [Related]
32. Risk stratification of metastatic neck nodes by CT and PET in patients with head and neck cancer receiving definitive radiotherapy.
Lin YC; Chen SW; Hsieh TC; Yen KY; Yang SN; Wang YC; Kao CH
J Nucl Med; 2015 Feb; 56(2):183-9. PubMed ID: 25613534
[TBL] [Abstract][Full Text] [Related]
33. Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma.
Nguyen N; Bellile E; Thomas D; McHugh J; Rozek L; Virani S; Peterson L; Carey TE; Walline H; Moyer J; Spector M; Perim D; Prince M; McLean S; Bradford CR; Taylor JM; Wolf GT;
Head Neck; 2016 Jul; 38(7):1074-84. PubMed ID: 26879675
[TBL] [Abstract][Full Text] [Related]
34. Radiotherapy potentiation with weekly cisplatin compared to standard every 3 weeks cisplatin chemotherapy for locoregionally advanced head and neck squamous cell carcinoma.
Fayette J; Molin Y; Lavergne E; Montbarbon X; Racadot S; Poupart M; Ramade A; Zrounba P; Ceruse P; Pommier P
Drug Des Devel Ther; 2015; 9():6203-10. PubMed ID: 26648696
[TBL] [Abstract][Full Text] [Related]
35. Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck.
Chau NG; Hurwitz S; Mitchell CM; Aserlind A; Grunfeld N; Kaplan L; Hsi P; Bauer DE; Lathan CS; Rodriguez-Galindo C; Tishler RB; Haddad RI; Sallan SE; Bradner JE; French CA
Cancer; 2016 Dec; 122(23):3632-3640. PubMed ID: 27509377
[TBL] [Abstract][Full Text] [Related]
36. Treatment of squamous cell carcinoma of external auditory canal: A tertiary cancer centre experience.
Gandhi AK; Roy S; Biswas A; Raza MW; Saxena T; Bhasker S; Sharma A; Thakar A; Mohanti BK
Auris Nasus Larynx; 2016 Feb; 43(1):45-9. PubMed ID: 26165629
[TBL] [Abstract][Full Text] [Related]
37. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.
Fakhry C; Westra WH; Li S; Cmelak A; Ridge JA; Pinto H; Forastiere A; Gillison ML
J Natl Cancer Inst; 2008 Feb; 100(4):261-9. PubMed ID: 18270337
[TBL] [Abstract][Full Text] [Related]
38. Impact of p16 expression, nodal status, and smoking on oncologic outcomes of patients with head and neck unknown primary squamous cell carcinoma.
Dixon PR; Au M; Hosni A; Perez-Ordonez B; Weinreb I; Xu W; Song Y; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
Head Neck; 2016 Sep; 38(9):1347-53. PubMed ID: 27002481
[TBL] [Abstract][Full Text] [Related]
39. Health care disparities among octogenarians and nonagenarians with stage III lung cancer.
Cassidy RJ; Zhang X; Switchenko JM; Patel PR; Shelton JW; Tian S; Nanda RH; Steuer CE; Pillai RN; Owonikoko TK; Ramalingam SS; Fernandez FG; Force SD; Gillespie TW; Curran WJ; Higgins KA
Cancer; 2018 Feb; 124(4):775-784. PubMed ID: 29315497
[TBL] [Abstract][Full Text] [Related]
40. Five-year quality of life results of the randomized clinical phase III (RADPLAT) trial, comparing concomitant intra-arterial versus intravenous chemoradiotherapy in locally advanced head and neck cancer.
Ackerstaff AH; Rasch CR; Balm AJ; de Boer JP; Wiggenraad R; Rietveld DH; Gregor RT; Kröger R; Hauptmann M; Vincent A; Hilgers FJ
Head Neck; 2012 Jul; 34(7):974-80. PubMed ID: 21818820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]